| Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn’s disease—new insights into dietary disease triggers M Logan, K Gkikas, V Svolos, B Nichols, S Milling, DR Gaya, JP Seenan, ... Alimentary Pharmacology & Therapeutics 51 (10), 935-947, 2020 | 82 | 2020 |
| The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re‐introduction M Logan, CM Clark, UZ Ijaz, L Gervais, H Duncan, V Garrick, L Curtis, ... Alimentary Pharmacology & Therapeutics 50 (6), 664-674, 2019 | 82 | 2019 |
| Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli MJ Ormsby, M Logan, SA Johnson, A McIntosh, G Fallata, ... EBioMedicine 43, 325-332, 2019 | 56 | 2019 |
| Intestinal fatty acid binding protein is a disease biomarker in paediatric coeliac disease and Crohn’s disease M Logan, M MacKinder, CM Clark, A Kountouri, M Jere, UZ Ijaz, ... BMC gastroenterology 22 (1), 260, 2022 | 26 | 2022 |
| The impact of compliance during exclusive enteral nutrition on faecal calprotectin in children with Crohn disease S Mckirdy, RK Russell, V Svolos, K Gkikas, M Logan, R Hansen, ... Journal of pediatric gastroenterology and nutrition 74 (6), 801-804, 2022 | 15 | 2022 |
| reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease M Logan, UZ Ijaz, R Hansen, K Gerasimidis, RK Russell Alimentary Pharmacology and Therapeutics 46 (11-12), 1119-1120, 2017 | 12 | 2017 |
| Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn’s disease: a pilot study K Gkikas, M Logan, B Nichols, UZ Ijaz, CM Clark, V Svolos, L Gervais, ... BMC gastroenterology 21, 1-11, 2021 | 10 | 2021 |
| Gut metabolome and microbiota signatures predict response to treatment with exclusive enteral nutrition in a prospective study in children with active Crohn’s disease B Nichols, A Briola, M Logan, J Havlik, A Mascellani, K Gkikas, S Milling, ... The American Journal of Clinical Nutrition 119 (4), 885-895, 2024 | 6 | 2024 |
| CD‐TREAT diet induces remission and improves quality of life in an open label trial in children and adults with active Crohn's disease V Svolos, R Hansen, R Russell, DR Gaya, S John Paul, J Macdonald J Crohns Colitis 16 (Suppl 1), i112, 2022 | 5 | 2022 |
| Comparing effectiveness of a generic oral nutritional supplement with specialized formula in the treatment of active pediatric Crohn’s disease R Dawson, DIF Wands, M Logan, G Bremner, S Efklides, L Benn, ... Inflammatory Bowel Diseases 28 (12), 1859-1864, 2022 | 4 | 2022 |
| An automated identification and analysis of ontological terms in gastrointestinal diseases and nutrition-related literature provides useful insights O Koci, M Logan, V Svolos, RK Russell, K Gerasimidis, UZ Ijaz PeerJ 6, e5047, 2018 | 3 | 2018 |
| Treatment of Active Crohn’s Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products C Kerbiriou, C Dickson, B Nichols, M Logan, A Mascellani, J Havlik, ... Inflammatory Bowel Diseases 30 (12), 2457-2466, 2024 | 2 | 2024 |
| Association of gut microbiota and gut metabolites and adverse outcomes in biliary atresia: A longitudinal prospective study V Jain, MJ Dalby, EC Alexander, C Burford, H Acford-Palmer, IR Serghiou, ... Hepatology Communications 8 (11), e0550, 2024 | 1 | 2024 |
| Identifying Key Bacteria in Microbiomes of Microplastics Found in Marine Environments for Possible Degradation M Logan University of Glasgow, 2023 | 1 | 2023 |
| O12 Reversion to baseline microbiome following successful course of exclusive enteral nutrition in paediatric Crohn’s disease M Logan, CM Clark, B Nichols, UZ Ijaz, S Milling, R Hansen, RK Russell, ... Gut 70 (Suppl 1), A6-A7, 2021 | 1 | 2021 |
| IBD 2 A comparison of the effectiveness of a generic oral nutritional supplement with a specialised formula in the treatment of active paediatric crohn’s disease D Wands, R Dawson, M Logan, J Meredith, S Efklides, L Benn, ... Frontline Gastroenterology 13 (Suppl 1), A37-A37, 2022 | | 2022 |
| The effect of compliance during exclusive enteral nutrition on faecal calprotectin levels in children with Crohn's disease S Mckirdy, R Russell, R Hansen, V Svolos, K Gkikas, M Logan, ... JOURNAL OF CROHNS & COLITIS 16, I347-I347, 2022 | | 2022 |
| DOP66 The effect of exclusive enteral nutrition on circulating inflammatory protein levels in paediatric patients with Crohn’s Disease M Pidoux, M Logan, S Milling, UZ Ijaz, R Hansen, RK Russell, ... Journal of Crohn's and Colitis 15 (Supplement_1), S100-S101, 2021 | | 2021 |
| DOP27 The fibre fermentative capacity of the gut microbiota is diminished in children with Crohn’s Disease and it is independent of disease activity or treatment with exclusive … K Gkikas, M Logan, S Milling, UZ Ijaz, R Hansen, RK Russell, ... Journal of Crohn's and Colitis 15 (Supplement_1), S065-S066, 2021 | | 2021 |
| P275 Analysis of exclusive enteral nutrition formulas in Crohn’s disease–new insights into dietary triggers M Logan, K Gkikas, V Svolos, B Nichols, S Milling, UZ Ijaz, J Macdonald, ... Gut 70 (Suppl 1), A183-A184, 2021 | | 2021 |
Konstantinos GerasimidisProfessor of Clinical NutritionVerified email at glasgow.ac.uk